Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Livent Corporation (“Livent” or the “Company”) (NYSE:LTHM) investors concerning the Company and its officers’ possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

On January 7, 2020, Livent reduced its fiscal 2019 guidance, expecting revenue between $385 million to $390 million, explaining that its “fourth quarter performance was negatively impacted by lower than forecasted realized pricing and by reduced lithium hydroxide volumes due to delayed customer orders.”

On this news, Livent’s stock price fell $0.98 per share, or more than 11%, to close at $7.69 per share on January 8, 2020, thereby injuring investors.

If you purchased Livent securities, have information, or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Charles H. Linehan, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, CA 90067 at 310-201-9150, Toll-Free at 888-773-9224, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number, and the number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.